Literature DB >> 25310526

+TIP EB1 downregulates paclitaxel‑induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules.

Geethu Emily Thomas1, Jamuna S Sreeja1, K K Gireesh1, Hindol Gupta1, Tapas K Manna1.   

Abstract

Microtubule plus‑end‑binding protein (+TIP) EB1 has been shown to be upregulated in breast cancer cells and promote breast tumor growth in vivo. However, its effect on the cellular actions of microtubule‑targeted drugs in breast cancer cells has remained poorly understood. By using cellular and biochemical assays, we demonstrate that EB1 plays a critical role in regulating the sensitivity of breast cancer cells to anti‑microtubule drug, paclitaxel (PTX). Cell viability assays revealed that EB1 expression in the breast cancer cell lines correlated with the reduction of their sensitivity to PTX. Knockdown of EB1 by enzymatically‑prepared siRNA pools (esiRNAs) increased PTX‑induced cytotoxicity and sensitized cells to PTX‑induced apoptosis in three breast cancer cell lines, MCF‑7, MDA MB‑231 and T47D. Apoptosis was associated with activation of caspase‑9 and an increase in the cleavage of poly(ADP‑ribose) polymerase (PARP). p53 and Bax were upregulated and Bcl2 was downregulated in the EB1‑depleted PTX‑treated MCF‑7 cells, indicating that the apoptosis occurs via a p53‑dependent pathway. Following its upregulation, the nuclear accumulation of p53 and its association with cellular microtubules were increased. EB1 depletion increased PTX‑induced microtubule bundling in the interphase cells and induced formation of multiple spindle foci with abnormally elongated spindles in the mitotic MCF‑7 cells, indicating that loss of EB1 promotes PTX‑induced stabilization of microtubules. EB1 inhibited PTX‑induced microtubule polymerization and diminished PTX binding to microtubules in vitro, suggesting that it modulates the binding sites of PTX at the growing microtubule ends. Results demonstrate that EB1 downregulates inhibition of PTX‑induced proliferation and apoptosis in breast cancer cells through a mechanism in which it impairs PTX‑mediated stabilization of microtubule polymerization and inhibits PTX binding on microtubules.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25310526     DOI: 10.3892/ijo.2014.2701

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Regulation of end-binding protein EB1 in the control of microtubule dynamics.

Authors:  Anne Nehlig; Angie Molina; Sylvie Rodrigues-Ferreira; Stéphane Honoré; Clara Nahmias
Journal:  Cell Mol Life Sci       Date:  2017-02-15       Impact factor: 9.261

Review 2.  Microtubule-Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy.

Authors:  Songbo Xie; Angela Ogden; Ritu Aneja; Jun Zhou
Journal:  Med Res Rev       Date:  2015-09-01       Impact factor: 12.944

Review 3.  Control of microtubule organization and dynamics: two ends in the limelight.

Authors:  Anna Akhmanova; Michel O Steinmetz
Journal:  Nat Rev Mol Cell Biol       Date:  2015-11-12       Impact factor: 94.444

4.  Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Authors:  Dana M Roque; Eric R Siegel; Natalia Buza; Stefania Bellone; Dan-Arin Silasi; Gloria S Huang; Vaagn Andikyan; Mitchell Clark; Masoud Azodi; Peter E Schwartz; Gautam G Rao; Jocelyn C Reader; Pei Hui; Joan R Tymon-Rosario; Justin Harold; Dennis Mauricio; Burak Zeybek; Gulden Menderes; Gary Altwerger; Elena Ratner; Alessandro D Santin
Journal:  Br J Cancer       Date:  2022-02-11       Impact factor: 7.640

5.  EB1 regulates attachment of Ska1 with microtubules by forming extended structures on the microtubule lattice.

Authors:  Geethu E Thomas; K Bandopadhyay; Sabyasachi Sutradhar; M R Renjith; Puja Singh; K K Gireesh; Steny Simon; Binshad Badarudeen; Hindol Gupta; Manidipa Banerjee; Raja Paul; J Mitra; Tapas K Manna
Journal:  Nat Commun       Date:  2016-05-26       Impact factor: 14.919

6.  Deacetylisovaltratum disrupts microtubule dynamics and causes G2/M-phase arrest in human gastric cancer cells in vitro.

Authors:  Dan Zhang; Bo Zhang; Li-Xin Zhou; Jun Zhao; You-You Yan; Yang-Ling Li; Jian-Mei Zeng; Lin-Ling Wang; Bo Yang; Neng-Ming Lin
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.